Interim analysis of a phase I/IIA trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients

2017 ◽  
Vol 145 ◽  
pp. 23
Author(s):  
G.L. Maxwell ◽  
J.C. Elkas ◽  
T.P. Conrads ◽  
K.M. Darcy ◽  
C.A. Hamilton ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Phase I ◽  
Cancer Patients ◽  
Interim Analysis ◽  
Binding Protein ◽  
Protein Vaccine ◽  
Folate Binding Protein ◽  
Gm Csf

scholarly journals Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients

Oncotarget ◽  
2016 ◽  
Vol 8 (9) ◽  
pp. 15912-15923 ◽  
Author(s):  
Doreen O. Jackson ◽  
Kevin Byrd ◽  
Timothy J. Vreeland ◽  
Diane F. Hale ◽  
Garth S. Herbert ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Phase I ◽  
Cancer Patients ◽  
Interim Analysis ◽  
Binding Protein ◽  
Protein Vaccine ◽  
Folate Binding Protein ◽  
Gm Csf

Preliminary results of the phase I/IIa dose finding trial of a folate binding protein vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e14031-e14031 ◽  
Author(s):  
Julia M. Greene ◽  
Erika J Schneble ◽  
John S. Berry ◽  
Alfred F. Trappey ◽  
Timothy J. Vreeland ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Phase I ◽  
Cancer Patients ◽  
Binding Protein ◽  
Dose Finding ◽  
Protein Vaccine ◽  
Folate Binding Protein ◽  
Preliminary Results ◽  
Gm Csf

scholarly journals Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients

2019 ◽  
Vol 8 (10) ◽  
pp. 4678-4687 ◽  
Author(s):  
Tommy A. Brown ◽  
Kevin Byrd ◽  
Timothy J. Vreeland ◽  
Guy T. Clifton ◽  
Doreen O. Jackson ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Phase I ◽  
Cancer Patients ◽  
Binding Protein ◽  
Peptide Vaccine ◽  
Final Analysis ◽  
Folate Binding Protein

Phase I/II Trial of Melanoma Patient–Specific Vaccine of Proliferating Autologous Tumor Cells, Dendritic Cells, and GM-CSF: Planned Interim Analysis

2004 ◽  
Vol 19 (5) ◽  
pp. 658-665 ◽  
Author(s):  
Robert Dillman ◽  
Senthamil Selvan ◽  
Patric Schiltz ◽  
Cheryl Peterson ◽  
Kanoe Allen ◽  
...  
Keyword(s):  
Dendritic Cells ◽  
Phase I ◽  
Tumor Cells ◽  
Melanoma Patient ◽  
Interim Analysis ◽  
Patient Specific ◽  
Autologous Tumor ◽  
Gm Csf
Sign in / Sign up

Export Citation Format

Share Document